Back to Search Start Over

Prednisolone: Central serous chorioretinopathy : case report.

Source :
Reactions Weekly. 8/24/2024, Vol. 2022 Issue 1, p238-238. 1p.
Publication Year :
2024

Abstract

A 34-year-old man developed central serous chorioretinopathy (CSCR) while being treated with prednisolone for type 1 lepra reaction. The man had leprosy and was on multidrug therapy for 3 months before starting prednisolone. An ocular examination revealed visual impairments in both eyes, and further tests confirmed CSCR. The patient stopped taking prednisolone and continued with multidrug therapy, and his vision improved after treatment with clofazimine. At his final follow-up visit, his vision had fully recovered. [Extracted from the article]

Details

Language :
English
ISSN :
01149954
Volume :
2022
Issue :
1
Database :
Academic Search Index
Journal :
Reactions Weekly
Publication Type :
Periodical
Accession number :
179233938
Full Text :
https://doi.org/10.1007/s40278-024-65558-5